Global Nuclear Medicine Supply, Demand and Key Producers, 2026-2032
The global Nuclear Medicine market size is expected to reach $ 12050 million by 2032, rising at a market growth of 7.2% CAGR during the forecast period (2026-2032).
Nuclear Medicine?or Radiopharmaceuticals? are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
Market Drivers
The nuclear medicine market is experiencing significant growth due to the increasing prevalence of chronic diseases, including cancer, cardiovascular diseases, and neurological disorders, which require advanced diagnostic and therapeutic solutions. Nuclear medicine provides highly targeted treatment, such as radioisotope therapy, and is crucial for precise imaging techniques like PET and SPECT, which offer better disease detection and management. Advances in radiopharmaceuticals, such as the development of new radioisotopes, and the rising demand for personalized medicine further fuel the market's expansion. Additionally, the growing emphasis on early diagnosis and treatment monitoring in healthcare systems, along with the availability of funding for research and development in nuclear medicine, contributes to market growth.
Market Challenges
Despite its advantages, the nuclear medicine market faces challenges related to the high costs of nuclear medicine treatments and imaging technologies. The infrastructure required for nuclear medicine, including specialized facilities, trained professionals, and the availability of radiopharmaceuticals, can be prohibitively expensive, especially in developing regions. Additionally, concerns over the safe handling and disposal of radioactive materials, regulatory hurdles, and the relatively short half-life of certain isotopes create logistical difficulties in terms of production, distribution, and patient access. These challenges can limit the widespread adoption of nuclear medicine, particularly in low-resource healthcare settings.
This report studies the global Nuclear Medicine demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Nuclear Medicine, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Nuclear Medicine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Nuclear Medicine total market, 2021-2032, (USD Million)
Global Nuclear Medicine total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Nuclear Medicine total market, key domestic companies, and share, (USD Million)
Global Nuclear Medicine revenue by player, revenue and market share 2021-2026, (USD Million)
Global Nuclear Medicine total market by Type, CAGR, 2021-2032, (USD Million)
Global Nuclear Medicine total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Nuclear Medicine market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cardinal Health, GE Healthcare, Jubilant Pharma, Novartis, Curium Pharma, SIEMENS, Lantheus, Bracco Imaging, Bayer, Eli Lilly, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Nuclear Medicine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Nuclear Medicine Market, By Region:
1. How big is the global Nuclear Medicine market?
2. What is the demand of the global Nuclear Medicine market?
3. What is the year over year growth of the global Nuclear Medicine market?
4. What is the total value of the global Nuclear Medicine market?
5. Who are the Major Players in the global Nuclear Medicine market?
6. What are the growth factors driving the market demand?
Nuclear Medicine?or Radiopharmaceuticals? are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
Market Drivers
The nuclear medicine market is experiencing significant growth due to the increasing prevalence of chronic diseases, including cancer, cardiovascular diseases, and neurological disorders, which require advanced diagnostic and therapeutic solutions. Nuclear medicine provides highly targeted treatment, such as radioisotope therapy, and is crucial for precise imaging techniques like PET and SPECT, which offer better disease detection and management. Advances in radiopharmaceuticals, such as the development of new radioisotopes, and the rising demand for personalized medicine further fuel the market's expansion. Additionally, the growing emphasis on early diagnosis and treatment monitoring in healthcare systems, along with the availability of funding for research and development in nuclear medicine, contributes to market growth.
Market Challenges
Despite its advantages, the nuclear medicine market faces challenges related to the high costs of nuclear medicine treatments and imaging technologies. The infrastructure required for nuclear medicine, including specialized facilities, trained professionals, and the availability of radiopharmaceuticals, can be prohibitively expensive, especially in developing regions. Additionally, concerns over the safe handling and disposal of radioactive materials, regulatory hurdles, and the relatively short half-life of certain isotopes create logistical difficulties in terms of production, distribution, and patient access. These challenges can limit the widespread adoption of nuclear medicine, particularly in low-resource healthcare settings.
This report studies the global Nuclear Medicine demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Nuclear Medicine, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Nuclear Medicine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Nuclear Medicine total market, 2021-2032, (USD Million)
Global Nuclear Medicine total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Nuclear Medicine total market, key domestic companies, and share, (USD Million)
Global Nuclear Medicine revenue by player, revenue and market share 2021-2026, (USD Million)
Global Nuclear Medicine total market by Type, CAGR, 2021-2032, (USD Million)
Global Nuclear Medicine total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Nuclear Medicine market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cardinal Health, GE Healthcare, Jubilant Pharma, Novartis, Curium Pharma, SIEMENS, Lantheus, Bracco Imaging, Bayer, Eli Lilly, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Nuclear Medicine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Nuclear Medicine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Diagnostic Nuclear Medicine
- Therapeutic Nuclear Medicine
- Oncology
- Thyroid
- Cardiology
- Others
- Cardinal Health
- GE Healthcare
- Jubilant Pharma
- Novartis
- Curium Pharma
- SIEMENS
- Lantheus
- Bracco Imaging
- Bayer
- Eli Lilly
- Aurobindo Pharma
- Mundipharma
- China Isotope & Radiation
- Yantai Dongcheng
1. How big is the global Nuclear Medicine market?
2. What is the demand of the global Nuclear Medicine market?
3. What is the year over year growth of the global Nuclear Medicine market?
4. What is the total value of the global Nuclear Medicine market?
5. Who are the Major Players in the global Nuclear Medicine market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Nuclear Medicine Introduction
1.2 World Nuclear Medicine Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Nuclear Medicine Total Market by Region (by Headquarter Location)
1.3.1 World Nuclear Medicine Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Nuclear Medicine Revenue (2021-2032)
1.3.3 China Based Company Nuclear Medicine Revenue (2021-2032)
1.3.4 Europe Based Company Nuclear Medicine Revenue (2021-2032)
1.3.5 Japan Based Company Nuclear Medicine Revenue (2021-2032)
1.3.6 South Korea Based Company Nuclear Medicine Revenue (2021-2032)
1.3.7 ASEAN Based Company Nuclear Medicine Revenue (2021-2032)
1.3.8 India Based Company Nuclear Medicine Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Nuclear Medicine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Nuclear Medicine Consumption Value (2021-2032)
2.2 World Nuclear Medicine Consumption Value by Region
2.2.1 World Nuclear Medicine Consumption Value by Region (2021-2026)
2.2.2 World Nuclear Medicine Consumption Value Forecast by Region (2027-2032)
2.3 United States Nuclear Medicine Consumption Value (2021-2032)
2.4 China Nuclear Medicine Consumption Value (2021-2032)
2.5 Europe Nuclear Medicine Consumption Value (2021-2032)
2.6 Japan Nuclear Medicine Consumption Value (2021-2032)
2.7 South Korea Nuclear Medicine Consumption Value (2021-2032)
2.8 ASEAN Nuclear Medicine Consumption Value (2021-2032)
2.9 India Nuclear Medicine Consumption Value (2021-2032)
3 WORLD NUCLEAR MEDICINE COMPANIES COMPETITIVE ANALYSIS
3.1 World Nuclear Medicine Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Nuclear Medicine Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Nuclear Medicine in 2025
3.2.3 Global Concentration Ratios (CR8) for Nuclear Medicine in 2025
3.3 Nuclear Medicine Company Evaluation Quadrant
3.4 Nuclear Medicine Market: Overall Company Footprint Analysis
3.4.1 Nuclear Medicine Market: Region Footprint
3.4.2 Nuclear Medicine Market: Company Product Type Footprint
3.4.3 Nuclear Medicine Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Nuclear Medicine Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Nuclear Medicine Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Nuclear Medicine Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Nuclear Medicine Consumption Value Comparison
4.2.1 United States VS China: Nuclear Medicine Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Nuclear Medicine Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Nuclear Medicine Companies and Market Share, 2021-2026
4.3.1 United States Based Nuclear Medicine Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Nuclear Medicine Revenue, (2021-2026)
4.4 China Based Companies Nuclear Medicine Revenue and Market Share, 2021-2026
4.4.1 China Based Nuclear Medicine Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Nuclear Medicine Revenue, (2021-2026)
4.5 Rest of World Based Nuclear Medicine Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Nuclear Medicine Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Nuclear Medicine Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Nuclear Medicine Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Diagnostic Nuclear Medicine
5.2.2 Therapeutic Nuclear Medicine
5.3 Market Segment by Type
5.3.1 World Nuclear Medicine Market Size by Type (2021-2026)
5.3.2 World Nuclear Medicine Market Size by Type (2027-2032)
5.3.3 World Nuclear Medicine Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Nuclear Medicine Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Oncology
6.2.2 Thyroid
6.2.3 Cardiology
6.2.4 Others
6.3 Market Segment by Application
6.3.1 World Nuclear Medicine Market Size by Application (2021-2026)
6.3.2 World Nuclear Medicine Market Size by Application (2027-2032)
6.3.3 World Nuclear Medicine Market Size Market Share by Application (2021-2032)
7 COMPANY PROFILES
7.1 Cardinal Health
7.1.1 Cardinal Health Details
7.1.2 Cardinal Health Major Business
7.1.3 Cardinal Health Nuclear Medicine Product and Services
7.1.4 Cardinal Health Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
7.1.5 Cardinal Health Recent Developments/Updates
7.1.6 Cardinal Health Competitive Strengths & Weaknesses
7.2 GE Healthcare
7.2.1 GE Healthcare Details
7.2.2 GE Healthcare Major Business
7.2.3 GE Healthcare Nuclear Medicine Product and Services
7.2.4 GE Healthcare Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
7.2.5 GE Healthcare Recent Developments/Updates
7.2.6 GE Healthcare Competitive Strengths & Weaknesses
7.3 Jubilant Pharma
7.3.1 Jubilant Pharma Details
7.3.2 Jubilant Pharma Major Business
7.3.3 Jubilant Pharma Nuclear Medicine Product and Services
7.3.4 Jubilant Pharma Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
7.3.5 Jubilant Pharma Recent Developments/Updates
7.3.6 Jubilant Pharma Competitive Strengths & Weaknesses
7.4 Novartis
7.4.1 Novartis Details
7.4.2 Novartis Major Business
7.4.3 Novartis Nuclear Medicine Product and Services
7.4.4 Novartis Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
7.4.5 Novartis Recent Developments/Updates
7.4.6 Novartis Competitive Strengths & Weaknesses
7.5 Curium Pharma
7.5.1 Curium Pharma Details
7.5.2 Curium Pharma Major Business
7.5.3 Curium Pharma Nuclear Medicine Product and Services
7.5.4 Curium Pharma Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
7.5.5 Curium Pharma Recent Developments/Updates
7.5.6 Curium Pharma Competitive Strengths & Weaknesses
7.6 SIEMENS
7.6.1 SIEMENS Details
7.6.2 SIEMENS Major Business
7.6.3 SIEMENS Nuclear Medicine Product and Services
7.6.4 SIEMENS Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
7.6.5 SIEMENS Recent Developments/Updates
7.6.6 SIEMENS Competitive Strengths & Weaknesses
7.7 Lantheus
7.7.1 Lantheus Details
7.7.2 Lantheus Major Business
7.7.3 Lantheus Nuclear Medicine Product and Services
7.7.4 Lantheus Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
7.7.5 Lantheus Recent Developments/Updates
7.7.6 Lantheus Competitive Strengths & Weaknesses
7.8 Bracco Imaging
7.8.1 Bracco Imaging Details
7.8.2 Bracco Imaging Major Business
7.8.3 Bracco Imaging Nuclear Medicine Product and Services
7.8.4 Bracco Imaging Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
7.8.5 Bracco Imaging Recent Developments/Updates
7.8.6 Bracco Imaging Competitive Strengths & Weaknesses
7.9 Bayer
7.9.1 Bayer Details
7.9.2 Bayer Major Business
7.9.3 Bayer Nuclear Medicine Product and Services
7.9.4 Bayer Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
7.9.5 Bayer Recent Developments/Updates
7.9.6 Bayer Competitive Strengths & Weaknesses
7.10 Eli Lilly
7.10.1 Eli Lilly Details
7.10.2 Eli Lilly Major Business
7.10.3 Eli Lilly Nuclear Medicine Product and Services
7.10.4 Eli Lilly Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
7.10.5 Eli Lilly Recent Developments/Updates
7.10.6 Eli Lilly Competitive Strengths & Weaknesses
7.11 Aurobindo Pharma
7.11.1 Aurobindo Pharma Details
7.11.2 Aurobindo Pharma Major Business
7.11.3 Aurobindo Pharma Nuclear Medicine Product and Services
7.11.4 Aurobindo Pharma Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
7.11.5 Aurobindo Pharma Recent Developments/Updates
7.11.6 Aurobindo Pharma Competitive Strengths & Weaknesses
7.12 Mundipharma
7.12.1 Mundipharma Details
7.12.2 Mundipharma Major Business
7.12.3 Mundipharma Nuclear Medicine Product and Services
7.12.4 Mundipharma Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
7.12.5 Mundipharma Recent Developments/Updates
7.12.6 Mundipharma Competitive Strengths & Weaknesses
7.13 China Isotope & Radiation
7.13.1 China Isotope & Radiation Details
7.13.2 China Isotope & Radiation Major Business
7.13.3 China Isotope & Radiation Nuclear Medicine Product and Services
7.13.4 China Isotope & Radiation Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
7.13.5 China Isotope & Radiation Recent Developments/Updates
7.13.6 China Isotope & Radiation Competitive Strengths & Weaknesses
7.14 Yantai Dongcheng
7.14.1 Yantai Dongcheng Details
7.14.2 Yantai Dongcheng Major Business
7.14.3 Yantai Dongcheng Nuclear Medicine Product and Services
7.14.4 Yantai Dongcheng Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
7.14.5 Yantai Dongcheng Recent Developments/Updates
7.14.6 Yantai Dongcheng Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Nuclear Medicine Industry Chain
8.2 Nuclear Medicine Upstream Analysis
8.3 Nuclear Medicine Midstream Analysis
8.4 Nuclear Medicine Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Nuclear Medicine Introduction
1.2 World Nuclear Medicine Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Nuclear Medicine Total Market by Region (by Headquarter Location)
1.3.1 World Nuclear Medicine Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Nuclear Medicine Revenue (2021-2032)
1.3.3 China Based Company Nuclear Medicine Revenue (2021-2032)
1.3.4 Europe Based Company Nuclear Medicine Revenue (2021-2032)
1.3.5 Japan Based Company Nuclear Medicine Revenue (2021-2032)
1.3.6 South Korea Based Company Nuclear Medicine Revenue (2021-2032)
1.3.7 ASEAN Based Company Nuclear Medicine Revenue (2021-2032)
1.3.8 India Based Company Nuclear Medicine Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Nuclear Medicine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Nuclear Medicine Consumption Value (2021-2032)
2.2 World Nuclear Medicine Consumption Value by Region
2.2.1 World Nuclear Medicine Consumption Value by Region (2021-2026)
2.2.2 World Nuclear Medicine Consumption Value Forecast by Region (2027-2032)
2.3 United States Nuclear Medicine Consumption Value (2021-2032)
2.4 China Nuclear Medicine Consumption Value (2021-2032)
2.5 Europe Nuclear Medicine Consumption Value (2021-2032)
2.6 Japan Nuclear Medicine Consumption Value (2021-2032)
2.7 South Korea Nuclear Medicine Consumption Value (2021-2032)
2.8 ASEAN Nuclear Medicine Consumption Value (2021-2032)
2.9 India Nuclear Medicine Consumption Value (2021-2032)
3 WORLD NUCLEAR MEDICINE COMPANIES COMPETITIVE ANALYSIS
3.1 World Nuclear Medicine Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Nuclear Medicine Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Nuclear Medicine in 2025
3.2.3 Global Concentration Ratios (CR8) for Nuclear Medicine in 2025
3.3 Nuclear Medicine Company Evaluation Quadrant
3.4 Nuclear Medicine Market: Overall Company Footprint Analysis
3.4.1 Nuclear Medicine Market: Region Footprint
3.4.2 Nuclear Medicine Market: Company Product Type Footprint
3.4.3 Nuclear Medicine Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Nuclear Medicine Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Nuclear Medicine Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Nuclear Medicine Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Nuclear Medicine Consumption Value Comparison
4.2.1 United States VS China: Nuclear Medicine Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Nuclear Medicine Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Nuclear Medicine Companies and Market Share, 2021-2026
4.3.1 United States Based Nuclear Medicine Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Nuclear Medicine Revenue, (2021-2026)
4.4 China Based Companies Nuclear Medicine Revenue and Market Share, 2021-2026
4.4.1 China Based Nuclear Medicine Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Nuclear Medicine Revenue, (2021-2026)
4.5 Rest of World Based Nuclear Medicine Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Nuclear Medicine Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Nuclear Medicine Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Nuclear Medicine Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Diagnostic Nuclear Medicine
5.2.2 Therapeutic Nuclear Medicine
5.3 Market Segment by Type
5.3.1 World Nuclear Medicine Market Size by Type (2021-2026)
5.3.2 World Nuclear Medicine Market Size by Type (2027-2032)
5.3.3 World Nuclear Medicine Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Nuclear Medicine Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Oncology
6.2.2 Thyroid
6.2.3 Cardiology
6.2.4 Others
6.3 Market Segment by Application
6.3.1 World Nuclear Medicine Market Size by Application (2021-2026)
6.3.2 World Nuclear Medicine Market Size by Application (2027-2032)
6.3.3 World Nuclear Medicine Market Size Market Share by Application (2021-2032)
7 COMPANY PROFILES
7.1 Cardinal Health
7.1.1 Cardinal Health Details
7.1.2 Cardinal Health Major Business
7.1.3 Cardinal Health Nuclear Medicine Product and Services
7.1.4 Cardinal Health Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
7.1.5 Cardinal Health Recent Developments/Updates
7.1.6 Cardinal Health Competitive Strengths & Weaknesses
7.2 GE Healthcare
7.2.1 GE Healthcare Details
7.2.2 GE Healthcare Major Business
7.2.3 GE Healthcare Nuclear Medicine Product and Services
7.2.4 GE Healthcare Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
7.2.5 GE Healthcare Recent Developments/Updates
7.2.6 GE Healthcare Competitive Strengths & Weaknesses
7.3 Jubilant Pharma
7.3.1 Jubilant Pharma Details
7.3.2 Jubilant Pharma Major Business
7.3.3 Jubilant Pharma Nuclear Medicine Product and Services
7.3.4 Jubilant Pharma Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
7.3.5 Jubilant Pharma Recent Developments/Updates
7.3.6 Jubilant Pharma Competitive Strengths & Weaknesses
7.4 Novartis
7.4.1 Novartis Details
7.4.2 Novartis Major Business
7.4.3 Novartis Nuclear Medicine Product and Services
7.4.4 Novartis Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
7.4.5 Novartis Recent Developments/Updates
7.4.6 Novartis Competitive Strengths & Weaknesses
7.5 Curium Pharma
7.5.1 Curium Pharma Details
7.5.2 Curium Pharma Major Business
7.5.3 Curium Pharma Nuclear Medicine Product and Services
7.5.4 Curium Pharma Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
7.5.5 Curium Pharma Recent Developments/Updates
7.5.6 Curium Pharma Competitive Strengths & Weaknesses
7.6 SIEMENS
7.6.1 SIEMENS Details
7.6.2 SIEMENS Major Business
7.6.3 SIEMENS Nuclear Medicine Product and Services
7.6.4 SIEMENS Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
7.6.5 SIEMENS Recent Developments/Updates
7.6.6 SIEMENS Competitive Strengths & Weaknesses
7.7 Lantheus
7.7.1 Lantheus Details
7.7.2 Lantheus Major Business
7.7.3 Lantheus Nuclear Medicine Product and Services
7.7.4 Lantheus Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
7.7.5 Lantheus Recent Developments/Updates
7.7.6 Lantheus Competitive Strengths & Weaknesses
7.8 Bracco Imaging
7.8.1 Bracco Imaging Details
7.8.2 Bracco Imaging Major Business
7.8.3 Bracco Imaging Nuclear Medicine Product and Services
7.8.4 Bracco Imaging Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
7.8.5 Bracco Imaging Recent Developments/Updates
7.8.6 Bracco Imaging Competitive Strengths & Weaknesses
7.9 Bayer
7.9.1 Bayer Details
7.9.2 Bayer Major Business
7.9.3 Bayer Nuclear Medicine Product and Services
7.9.4 Bayer Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
7.9.5 Bayer Recent Developments/Updates
7.9.6 Bayer Competitive Strengths & Weaknesses
7.10 Eli Lilly
7.10.1 Eli Lilly Details
7.10.2 Eli Lilly Major Business
7.10.3 Eli Lilly Nuclear Medicine Product and Services
7.10.4 Eli Lilly Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
7.10.5 Eli Lilly Recent Developments/Updates
7.10.6 Eli Lilly Competitive Strengths & Weaknesses
7.11 Aurobindo Pharma
7.11.1 Aurobindo Pharma Details
7.11.2 Aurobindo Pharma Major Business
7.11.3 Aurobindo Pharma Nuclear Medicine Product and Services
7.11.4 Aurobindo Pharma Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
7.11.5 Aurobindo Pharma Recent Developments/Updates
7.11.6 Aurobindo Pharma Competitive Strengths & Weaknesses
7.12 Mundipharma
7.12.1 Mundipharma Details
7.12.2 Mundipharma Major Business
7.12.3 Mundipharma Nuclear Medicine Product and Services
7.12.4 Mundipharma Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
7.12.5 Mundipharma Recent Developments/Updates
7.12.6 Mundipharma Competitive Strengths & Weaknesses
7.13 China Isotope & Radiation
7.13.1 China Isotope & Radiation Details
7.13.2 China Isotope & Radiation Major Business
7.13.3 China Isotope & Radiation Nuclear Medicine Product and Services
7.13.4 China Isotope & Radiation Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
7.13.5 China Isotope & Radiation Recent Developments/Updates
7.13.6 China Isotope & Radiation Competitive Strengths & Weaknesses
7.14 Yantai Dongcheng
7.14.1 Yantai Dongcheng Details
7.14.2 Yantai Dongcheng Major Business
7.14.3 Yantai Dongcheng Nuclear Medicine Product and Services
7.14.4 Yantai Dongcheng Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
7.14.5 Yantai Dongcheng Recent Developments/Updates
7.14.6 Yantai Dongcheng Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Nuclear Medicine Industry Chain
8.2 Nuclear Medicine Upstream Analysis
8.3 Nuclear Medicine Midstream Analysis
8.4 Nuclear Medicine Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Nuclear Medicine Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Nuclear Medicine Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Nuclear Medicine Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Nuclear Medicine Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Nuclear Medicine Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Nuclear Medicine Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Nuclear Medicine Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Nuclear Medicine Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Nuclear Medicine Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Nuclear Medicine Players in 2025
Table 12. World Nuclear Medicine Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Nuclear Medicine Company Evaluation Quadrant
Table 14. Head Office of Key Nuclear Medicine Players
Table 15. Nuclear Medicine Market: Company Product Type Footprint
Table 16. Nuclear Medicine Market: Company Product Application Footprint
Table 17. Nuclear Medicine Mergers & Acquisitions Activity
Table 18. United States VS China Nuclear Medicine Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Nuclear Medicine Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Nuclear Medicine Companies, Headquarters (States, Country)
Table 21. United States Based Companies Nuclear Medicine Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Nuclear Medicine Revenue Market Share (2021-2026)
Table 23. China Based Nuclear Medicine Companies, Headquarters (Province, Country)
Table 24. China Based Companies Nuclear Medicine Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Nuclear Medicine Revenue Market Share (2021-2026)
Table 26. Rest of World Based Nuclear Medicine Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Nuclear Medicine Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Nuclear Medicine Revenue Market Share (2021-2026)
Table 29. World Nuclear Medicine Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Nuclear Medicine Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Nuclear Medicine Market Size by Type (2027-2032) & (USD Million)
Table 32. World Nuclear Medicine Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 33. World Nuclear Medicine Market Size by Application (2021-2026) & (USD Million)
Table 34. World Nuclear Medicine Market Size by Application (2027-2032) & (USD Million)
Table 35. Cardinal Health Basic Information, Manufacturing Base and Competitors
Table 36. Cardinal Health Major Business
Table 37. Cardinal Health Nuclear Medicine Product and Services
Table 38. Cardinal Health Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 39. Cardinal Health Recent Developments/Updates
Table 40. Cardinal Health Competitive Strengths & Weaknesses
Table 41. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 42. GE Healthcare Major Business
Table 43. GE Healthcare Nuclear Medicine Product and Services
Table 44. GE Healthcare Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. GE Healthcare Recent Developments/Updates
Table 46. GE Healthcare Competitive Strengths & Weaknesses
Table 47. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 48. Jubilant Pharma Major Business
Table 49. Jubilant Pharma Nuclear Medicine Product and Services
Table 50. Jubilant Pharma Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Jubilant Pharma Recent Developments/Updates
Table 52. Jubilant Pharma Competitive Strengths & Weaknesses
Table 53. Novartis Basic Information, Manufacturing Base and Competitors
Table 54. Novartis Major Business
Table 55. Novartis Nuclear Medicine Product and Services
Table 56. Novartis Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Novartis Recent Developments/Updates
Table 58. Novartis Competitive Strengths & Weaknesses
Table 59. Curium Pharma Basic Information, Manufacturing Base and Competitors
Table 60. Curium Pharma Major Business
Table 61. Curium Pharma Nuclear Medicine Product and Services
Table 62. Curium Pharma Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Curium Pharma Recent Developments/Updates
Table 64. Curium Pharma Competitive Strengths & Weaknesses
Table 65. SIEMENS Basic Information, Manufacturing Base and Competitors
Table 66. SIEMENS Major Business
Table 67. SIEMENS Nuclear Medicine Product and Services
Table 68. SIEMENS Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. SIEMENS Recent Developments/Updates
Table 70. SIEMENS Competitive Strengths & Weaknesses
Table 71. Lantheus Basic Information, Manufacturing Base and Competitors
Table 72. Lantheus Major Business
Table 73. Lantheus Nuclear Medicine Product and Services
Table 74. Lantheus Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Lantheus Recent Developments/Updates
Table 76. Lantheus Competitive Strengths & Weaknesses
Table 77. Bracco Imaging Basic Information, Manufacturing Base and Competitors
Table 78. Bracco Imaging Major Business
Table 79. Bracco Imaging Nuclear Medicine Product and Services
Table 80. Bracco Imaging Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Bracco Imaging Recent Developments/Updates
Table 82. Bracco Imaging Competitive Strengths & Weaknesses
Table 83. Bayer Basic Information, Manufacturing Base and Competitors
Table 84. Bayer Major Business
Table 85. Bayer Nuclear Medicine Product and Services
Table 86. Bayer Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Bayer Recent Developments/Updates
Table 88. Bayer Competitive Strengths & Weaknesses
Table 89. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 90. Eli Lilly Major Business
Table 91. Eli Lilly Nuclear Medicine Product and Services
Table 92. Eli Lilly Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Eli Lilly Recent Developments/Updates
Table 94. Eli Lilly Competitive Strengths & Weaknesses
Table 95. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 96. Aurobindo Pharma Major Business
Table 97. Aurobindo Pharma Nuclear Medicine Product and Services
Table 98. Aurobindo Pharma Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Aurobindo Pharma Recent Developments/Updates
Table 100. Aurobindo Pharma Competitive Strengths & Weaknesses
Table 101. Mundipharma Basic Information, Manufacturing Base and Competitors
Table 102. Mundipharma Major Business
Table 103. Mundipharma Nuclear Medicine Product and Services
Table 104. Mundipharma Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Mundipharma Recent Developments/Updates
Table 106. Mundipharma Competitive Strengths & Weaknesses
Table 107. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 108. China Isotope & Radiation Major Business
Table 109. China Isotope & Radiation Nuclear Medicine Product and Services
Table 110. China Isotope & Radiation Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. China Isotope & Radiation Recent Developments/Updates
Table 112. China Isotope & Radiation Competitive Strengths & Weaknesses
Table 113. Yantai Dongcheng Basic Information, Manufacturing Base and Competitors
Table 114. Yantai Dongcheng Major Business
Table 115. Yantai Dongcheng Nuclear Medicine Product and Services
Table 116. Yantai Dongcheng Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Yantai Dongcheng Recent Developments/Updates
Table 118. Yantai Dongcheng Competitive Strengths & Weaknesses
Table 119. Global Key Players of Nuclear Medicine Upstream (Raw Materials)
Table 120. Global Nuclear Medicine Typical Customers
Table 1. World Nuclear Medicine Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Nuclear Medicine Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Nuclear Medicine Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Nuclear Medicine Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Nuclear Medicine Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Nuclear Medicine Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Nuclear Medicine Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Nuclear Medicine Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Nuclear Medicine Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Nuclear Medicine Players in 2025
Table 12. World Nuclear Medicine Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Nuclear Medicine Company Evaluation Quadrant
Table 14. Head Office of Key Nuclear Medicine Players
Table 15. Nuclear Medicine Market: Company Product Type Footprint
Table 16. Nuclear Medicine Market: Company Product Application Footprint
Table 17. Nuclear Medicine Mergers & Acquisitions Activity
Table 18. United States VS China Nuclear Medicine Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Nuclear Medicine Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Nuclear Medicine Companies, Headquarters (States, Country)
Table 21. United States Based Companies Nuclear Medicine Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Nuclear Medicine Revenue Market Share (2021-2026)
Table 23. China Based Nuclear Medicine Companies, Headquarters (Province, Country)
Table 24. China Based Companies Nuclear Medicine Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Nuclear Medicine Revenue Market Share (2021-2026)
Table 26. Rest of World Based Nuclear Medicine Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Nuclear Medicine Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Nuclear Medicine Revenue Market Share (2021-2026)
Table 29. World Nuclear Medicine Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Nuclear Medicine Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Nuclear Medicine Market Size by Type (2027-2032) & (USD Million)
Table 32. World Nuclear Medicine Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 33. World Nuclear Medicine Market Size by Application (2021-2026) & (USD Million)
Table 34. World Nuclear Medicine Market Size by Application (2027-2032) & (USD Million)
Table 35. Cardinal Health Basic Information, Manufacturing Base and Competitors
Table 36. Cardinal Health Major Business
Table 37. Cardinal Health Nuclear Medicine Product and Services
Table 38. Cardinal Health Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 39. Cardinal Health Recent Developments/Updates
Table 40. Cardinal Health Competitive Strengths & Weaknesses
Table 41. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 42. GE Healthcare Major Business
Table 43. GE Healthcare Nuclear Medicine Product and Services
Table 44. GE Healthcare Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. GE Healthcare Recent Developments/Updates
Table 46. GE Healthcare Competitive Strengths & Weaknesses
Table 47. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 48. Jubilant Pharma Major Business
Table 49. Jubilant Pharma Nuclear Medicine Product and Services
Table 50. Jubilant Pharma Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Jubilant Pharma Recent Developments/Updates
Table 52. Jubilant Pharma Competitive Strengths & Weaknesses
Table 53. Novartis Basic Information, Manufacturing Base and Competitors
Table 54. Novartis Major Business
Table 55. Novartis Nuclear Medicine Product and Services
Table 56. Novartis Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Novartis Recent Developments/Updates
Table 58. Novartis Competitive Strengths & Weaknesses
Table 59. Curium Pharma Basic Information, Manufacturing Base and Competitors
Table 60. Curium Pharma Major Business
Table 61. Curium Pharma Nuclear Medicine Product and Services
Table 62. Curium Pharma Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Curium Pharma Recent Developments/Updates
Table 64. Curium Pharma Competitive Strengths & Weaknesses
Table 65. SIEMENS Basic Information, Manufacturing Base and Competitors
Table 66. SIEMENS Major Business
Table 67. SIEMENS Nuclear Medicine Product and Services
Table 68. SIEMENS Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. SIEMENS Recent Developments/Updates
Table 70. SIEMENS Competitive Strengths & Weaknesses
Table 71. Lantheus Basic Information, Manufacturing Base and Competitors
Table 72. Lantheus Major Business
Table 73. Lantheus Nuclear Medicine Product and Services
Table 74. Lantheus Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Lantheus Recent Developments/Updates
Table 76. Lantheus Competitive Strengths & Weaknesses
Table 77. Bracco Imaging Basic Information, Manufacturing Base and Competitors
Table 78. Bracco Imaging Major Business
Table 79. Bracco Imaging Nuclear Medicine Product and Services
Table 80. Bracco Imaging Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Bracco Imaging Recent Developments/Updates
Table 82. Bracco Imaging Competitive Strengths & Weaknesses
Table 83. Bayer Basic Information, Manufacturing Base and Competitors
Table 84. Bayer Major Business
Table 85. Bayer Nuclear Medicine Product and Services
Table 86. Bayer Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Bayer Recent Developments/Updates
Table 88. Bayer Competitive Strengths & Weaknesses
Table 89. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 90. Eli Lilly Major Business
Table 91. Eli Lilly Nuclear Medicine Product and Services
Table 92. Eli Lilly Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Eli Lilly Recent Developments/Updates
Table 94. Eli Lilly Competitive Strengths & Weaknesses
Table 95. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 96. Aurobindo Pharma Major Business
Table 97. Aurobindo Pharma Nuclear Medicine Product and Services
Table 98. Aurobindo Pharma Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Aurobindo Pharma Recent Developments/Updates
Table 100. Aurobindo Pharma Competitive Strengths & Weaknesses
Table 101. Mundipharma Basic Information, Manufacturing Base and Competitors
Table 102. Mundipharma Major Business
Table 103. Mundipharma Nuclear Medicine Product and Services
Table 104. Mundipharma Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Mundipharma Recent Developments/Updates
Table 106. Mundipharma Competitive Strengths & Weaknesses
Table 107. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 108. China Isotope & Radiation Major Business
Table 109. China Isotope & Radiation Nuclear Medicine Product and Services
Table 110. China Isotope & Radiation Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. China Isotope & Radiation Recent Developments/Updates
Table 112. China Isotope & Radiation Competitive Strengths & Weaknesses
Table 113. Yantai Dongcheng Basic Information, Manufacturing Base and Competitors
Table 114. Yantai Dongcheng Major Business
Table 115. Yantai Dongcheng Nuclear Medicine Product and Services
Table 116. Yantai Dongcheng Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Yantai Dongcheng Recent Developments/Updates
Table 118. Yantai Dongcheng Competitive Strengths & Weaknesses
Table 119. Global Key Players of Nuclear Medicine Upstream (Raw Materials)
Table 120. Global Nuclear Medicine Typical Customers
LIST OF FIGURES
Figure 1. Nuclear Medicine Picture
Figure 2. World Nuclear Medicine Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Nuclear Medicine Total Revenue (2021-2032) & (USD Million)
Figure 4. World Nuclear Medicine Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Nuclear Medicine Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Nuclear Medicine Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Nuclear Medicine Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Nuclear Medicine Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Nuclear Medicine Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Nuclear Medicine Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Nuclear Medicine Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Nuclear Medicine Revenue (2021-2032) & (USD Million)
Figure 13. Nuclear Medicine Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 16. World Nuclear Medicine Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 18. China Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 23. India Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Nuclear Medicine by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Nuclear Medicine Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Nuclear Medicine Markets in 2025
Figure 27. United States VS China: Nuclear Medicine Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Nuclear Medicine Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Nuclear Medicine Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Nuclear Medicine Market Size Market Share by Type in 2025
Figure 31. Diagnostic Nuclear Medicine
Figure 32. Therapeutic Nuclear Medicine
Figure 33. World Nuclear Medicine Market Size Market Share by Type (2021-2032)
Figure 34. World Nuclear Medicine Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 35. World Nuclear Medicine Market Size Market Share by Application in 2025
Figure 36. Oncology
Figure 37. Thyroid
Figure 38. Cardiology
Figure 39. Others
Figure 40. World Nuclear Medicine Market Size Market Share by Application (2021-2032)
Figure 41. Nuclear Medicine Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
Figure 1. Nuclear Medicine Picture
Figure 2. World Nuclear Medicine Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Nuclear Medicine Total Revenue (2021-2032) & (USD Million)
Figure 4. World Nuclear Medicine Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Nuclear Medicine Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Nuclear Medicine Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Nuclear Medicine Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Nuclear Medicine Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Nuclear Medicine Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Nuclear Medicine Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Nuclear Medicine Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Nuclear Medicine Revenue (2021-2032) & (USD Million)
Figure 13. Nuclear Medicine Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 16. World Nuclear Medicine Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 18. China Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 23. India Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Nuclear Medicine by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Nuclear Medicine Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Nuclear Medicine Markets in 2025
Figure 27. United States VS China: Nuclear Medicine Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Nuclear Medicine Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Nuclear Medicine Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Nuclear Medicine Market Size Market Share by Type in 2025
Figure 31. Diagnostic Nuclear Medicine
Figure 32. Therapeutic Nuclear Medicine
Figure 33. World Nuclear Medicine Market Size Market Share by Type (2021-2032)
Figure 34. World Nuclear Medicine Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 35. World Nuclear Medicine Market Size Market Share by Application in 2025
Figure 36. Oncology
Figure 37. Thyroid
Figure 38. Cardiology
Figure 39. Others
Figure 40. World Nuclear Medicine Market Size Market Share by Application (2021-2032)
Figure 41. Nuclear Medicine Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
